Suzhou Highfine Biotech Co., Ltd. (SHE:301393)
China · Delayed Price · Currency is CNY 59.60
+0.75 (1.27%)
At close: Aug 18, 2025, 2:57 PM CST
Suzhou Highfine Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 139.02 | 134.05 | 98.97 | 129.37 | 111.4 | 40.4 | Upgrade |
Depreciation & Amortization | 19.99 | 19.99 | 14.19 | 11.66 | 6.86 | 2.01 | Upgrade |
Other Amortization | 0.08 | 0.08 | 0.18 | 0.12 | 0.06 | 0.04 | Upgrade |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | 0 | 0.12 | 0.03 | -0 | Upgrade |
Asset Writedown & Restructuring Costs | 0.36 | 0.36 | 0.08 | 0.28 | 1.79 | 0.03 | Upgrade |
Loss (Gain) From Sale of Investments | -16.59 | -16.59 | -1.73 | -0.4 | -1.18 | -0.91 | Upgrade |
Other Operating Activities | -13.96 | 1.61 | 4.97 | -3.44 | 2.42 | 5.77 | Upgrade |
Change in Accounts Receivable | -25.75 | -25.75 | -18.72 | 5.08 | -45.34 | -12.27 | Upgrade |
Change in Inventory | -4.37 | -4.37 | -6.08 | -35.35 | -26.57 | -9.59 | Upgrade |
Change in Accounts Payable | 13.14 | 13.14 | -6.54 | 32.09 | 27.37 | 17.05 | Upgrade |
Change in Other Net Operating Assets | 4.54 | 4.54 | 2.23 | 0.59 | 0.33 | 47.02 | Upgrade |
Operating Cash Flow | 115.77 | 126.37 | 87.83 | 138.67 | 75.97 | 89.17 | Upgrade |
Operating Cash Flow Growth | -5.97% | 43.88% | -36.66% | 82.53% | -14.80% | 194.02% | Upgrade |
Capital Expenditures | -119.66 | -107.75 | -120.47 | -81.4 | -53.56 | -67.43 | Upgrade |
Sale of Property, Plant & Equipment | 0.1 | 0.08 | 0.86 | 0.05 | 0 | 0.01 | Upgrade |
Investment in Securities | -1,097 | -1,310 | 29.47 | -15 | -35 | -10 | Upgrade |
Other Investing Activities | 478.15 | 478.15 | -475.21 | 2.13 | 46.7 | 4.2 | Upgrade |
Investing Cash Flow | -738.4 | -939.35 | -565.36 | -94.23 | -41.85 | -73.23 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 1 | Upgrade |
Total Debt Issued | - | - | - | - | - | 1 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -1 | - | Upgrade |
Long-Term Debt Repaid | - | -2.31 | -1.41 | -1.5 | -0.85 | - | Upgrade |
Total Debt Repaid | -2.31 | -2.31 | -1.41 | -1.5 | -1.85 | - | Upgrade |
Net Debt Issued (Repaid) | -2.31 | -2.31 | -1.41 | -1.5 | -1.85 | 1 | Upgrade |
Issuance of Common Stock | - | - | 1,683 | - | - | - | Upgrade |
Repurchase of Common Stock | -42 | -42 | - | - | - | - | Upgrade |
Common Dividends Paid | -40.19 | -40.19 | -27 | -20.25 | -0.01 | -0.03 | Upgrade |
Other Financing Activities | 9.15 | - | -21.17 | - | - | - | Upgrade |
Financing Cash Flow | -75.35 | -84.5 | 1,634 | -21.75 | -1.86 | 0.97 | Upgrade |
Foreign Exchange Rate Adjustments | 2.81 | 3.33 | -0.01 | 1.98 | -2.33 | -5.82 | Upgrade |
Net Cash Flow | -695.17 | -894.16 | 1,156 | 24.67 | 29.93 | 11.09 | Upgrade |
Free Cash Flow | -3.89 | 18.62 | -32.64 | 57.27 | 22.42 | 21.74 | Upgrade |
Free Cash Flow Growth | - | - | - | 155.48% | 3.12% | 123.64% | Upgrade |
Free Cash Flow Margin | -0.78% | 4.12% | -8.40% | 12.80% | 6.07% | 7.70% | Upgrade |
Free Cash Flow Per Share | -0.04 | 0.17 | -0.35 | 0.71 | 0.28 | 0.27 | Upgrade |
Cash Income Tax Paid | 17.27 | 11.73 | 22.37 | 16.58 | 20.47 | 2,578 | Upgrade |
Levered Free Cash Flow | -90.69 | -59.8 | -100.31 | 17.22 | -1.56 | 39.28 | Upgrade |
Unlevered Free Cash Flow | -90.62 | -59.74 | -100.28 | 17.37 | -1.5 | 39.3 | Upgrade |
Change in Working Capital | -13.16 | -13.16 | -28.83 | 0.95 | -45.42 | 41.83 | Upgrade |
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.